Sign In
Buy CSLLY
$21.64
-1.12 (-4.92%)
At Close: Jul 31, 2026
CSL Q2 Earnings Beat Estimates on Record Sales, Outlook Raised
12:41pm, Thursday, 30'th Jul 2026
Carlisle tops Q2 earnings and revenue estimates, posts record sales and raises its 2026 outlook as organic growth supported both reporting segments.
CSL to start clinical trials for new immunoglobulin manufacturing process
09:00pm, Tuesday, 28'th Jul 2026
Australian biotechnology firm CSL said on Wednesday it would start clinical trials to support regulatory approval for a new manufacturing process aimed at lifting immunoglobulin output from the
CSL plans to begin submitting regulatory filings for expanded pediatric indication for ANDEMBRY in the first half of the company's fiscal year Full data to be presented at upcoming scientific congress
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
09:00am, Friday, 26'th Jun 2026
Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNew
CSL Delivers World's First Battery-Powered Self-Unloading Bulk Carrier to Support Adbri Operations
12:35pm, Friday, 12'th Jun 2026
SYDNEY, June 12, 2026 (GLOBE NEWSWIRE) -- The CSL Group (“CSL”), a global leader in responsible marine transportation services, and Adbri announce the delivery of MV Yampu, the world's first batte
Australia says CSL unit Seqirus to discontinue Benpen injections from November
03:20am, Wednesday, 27'th May 2026
Australia's drug regulator said on Wednesday it was notified by biopharmaceutical giant CSL's unit Seqirus that it will be discontinuing all strengths of their Benpen injection
CSL Limited (CSLLY) Shareholder/Analyst Call Transcript
03:30pm, Thursday, 14'th May 2026
CSL Limited (CSLLY) Shareholder/Analyst Call Transcript
CSL: The Plasma Moat Is Being Rebuilt While The Market Prices The Noise
03:44am, Tuesday, 05'th May 2026
CSL trades at a discount despite owning a dominant, hard-to-replicate global plasma-derived therapies infrastructure. Transformation Program targets $500–$550M in annual pre-tax cost reductions by F
Should Value Investors Buy CSL Limited (CSLLY) Stock?
10:40am, Monday, 04'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
12:40pm, Thursday, 30'th Apr 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limited Sponsored ADR (CSLLY) and Acadia Pharmaceuticals (ACAD). But which of these two stocks offers valu
Carlisle Companies: Resilient In Challenging Sector Backdrop
10:21am, Friday, 24'th Apr 2026
Carlisle Companies Incorporated still faces a challenging macroeconomic backdrop. CSL's Q1 sales performance reflects macroeconomic weakness but also a transitory headwind from harsh winter weather. P
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
12:40pm, Tuesday, 14'th Apr 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and Acadia Pharmaceuticals (ACAD). But which of these two stocks i
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 24'th Mar 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both CSL Limited Sponsored ADR (CSLLY) and argenex SE (ARGX). But which of these two companies is the bes
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
12:40pm, Monday, 23'rd Mar 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either CSL Limited Sponsored ADR (CSLLY) or argenex SE (ARGX). But which of these two stocks is more
Analyzing CSL (OTCMKTS:CSLLY) and Ascentage Pharma Group International (NASDAQ:AAPG)
02:24am, Thursday, 12'th Mar 2026
CSL (OTCMKTS:CSLLY - Get Free Report) and Ascentage Pharma Group International (NASDAQ: AAPG - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two comp
